Disopyramide Free Base en es it fr

Disopyramide Free Base Brand names, Disopyramide Free Base Analogs

Disopyramide Free Base Brand Names Mixture

  • No information avaliable

Disopyramide Free Base Chemical_Formula

C21H29N3O

Disopyramide Free Base RX_link

http://www.rxlist.com/cgi/generic2/disopyr.htm

Disopyramide Free Base fda sheet

Disopyramide Free Base msds (material safety sheet)

Disopyramide Free Base Synthesis Reference

No information avaliable

Disopyramide Free Base Molecular Weight

339.475 g/mol

Disopyramide Free Base Melting Point

94.5-95 oC

Disopyramide Free Base H2O Solubility

44.9 mg/L

Disopyramide Free Base State

Solid

Disopyramide Free Base LogP

3.972

Disopyramide Free Base Dosage Forms

Capsule; Tablet (extended-release)

Disopyramide Free Base Indication

For the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, ventricular pre-excitation and cardiac dysrhythmias.

Disopyramide Free Base Pharmacology

Disopyramide is an antiarrhythmic drug indicated for the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia that are life-threatening. In man, Disopyramide at therapeutic plasma levels shortens the sinus node recovery time, lengthens the effective refractory period of the atrium, and has a minimal effect on the effective refractory period of the AV node. Little effect has been shown on AV-nodal and His-Purkinje conduction times or QRS duration. However, prolongation of conduction in accessory pathways occurs.

Disopyramide Free Base Absorption

Nearly complete

Disopyramide Free Base side effects and Toxicity

LD50=580 mg/kg in rats

Disopyramide Free Base Patient Information

No information avaliable

Disopyramide Free Base Organisms Affected

Humans and other mammals